文献速递脊柱关节炎

银屑病关节炎患者可接受症状状态(PASS)与疾病活动度及生活质量指标的关联评估

Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices.
PubMed 文献 · RMD Open · 2020-01-01

本研究为横断面研究,纳入连续银屑病关节炎(PsA)患者,评估PASS根据疾病活动度、缓解/低疾病活动度指标及生活质量指标的判别能力。结果显示,PASS应答为“是”的患者DAPSA评分、全身炎症水平、附着点炎指数、PsAID及疼痛均显著更低、功能更好;PASS与MDA、DAPSA低疾病活动度及PsAID≤4呈中至良好一致性,对DAPSA低疾病活动度敏感性和特异性良好,但对MDA、DAPSA缓解及VLDA识别敏感而特异性不足。

要点

  • PASS应答为“是”的PsA患者DAPSA评分及全身炎症水平显著更低。
  • PASS与MDA、DAPSA低疾病活动度及PsAID≤4呈中至良好一致性。
  • PASS对DAPSA低疾病活动度敏感性和特异性良好,但对MDA/VLDA特异性不足。

核心结论

  • PASS或可作为真实临床实践中评估PsA疾病活动度的替代工具,主要用于DAPSA低疾病活动度患者。

研究设计与样本

  • 横断面研究,连续纳入银屑病关节炎(PsA)患者,每次访视进行完整体格检查并收集临床/实验室数据。
  • 疾病活动度采用DAPSA评估,缓解/低疾病活动度采用DAPSA的MDA和VLDA标准,并收集PsAID和HAQ-DI评分。
  • PASS通过单问题让所有患者回答“是”或“否”进行评估。

主要发现

  • PASS应答为“是”的患者总体平均DAPSA评分显著优于非PASS患者。
  • PASS患者全身炎症水平、Leeds附着点炎指数评分、PsAID疾病影响、疼痛显著更低,功能更好。
  • PASS与MDA、DAPSA低疾病活动度及PsAID评分≤4之间呈中至良好一致性。
  • PASS对DAPSA低疾病活动度具有良好敏感性和特异性。
  • PASS对识别MDA、DAPSA缓解和VLDA患者敏感但缺乏特异性。

关键数值与推荐

  • PASS通过单问题回答“是”或“否”定义。
  • 疾病活动度采用DAPSA评估,低疾病活动度采用DAPSA标准,缓解/低疾病活动度采用MDA和VLDA标准。
  • 生活质量指标包括PsAID和HAQ-DI,PsAID评分≤4用于一致性分析。

临床怎么用

  • 在真实临床实践中,PASS可考虑作为评估PsA疾病活动度的替代工具,尤其适用于DAPSA低疾病活动度患者。
  • PASS对MDA、DAPSA缓解和VLDA识别特异性不足,临床解读时需结合其他疾病活动度指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to evaluate the discriminant capability of the Patient Acceptable Symptom State (PASS) according to disease activity, remission/low disease activity indices and quality of life indices in patients with psoriatic arthritis (PsA). METHODS: Consecutive patients with PsA were enrolled in this cross-sectional study. At each visit, the patients underwent a complete physical examination and their clinical/laboratory data were collected. Disease activity was assessed using the Disease Activity Score for Psoriatic Arthritis (DAPSA) and remission/low disease activity using the DAPSA minimal disease activity (MDA) and very low disease activity (VLDA) criteria. The Psoriatic Arthritis Impact of Disease (PsAID) and the Health Assessment Questionnaire-Disability Index scores were also collected. Finally, PASS was assessed by asking all patients to answer yes or no to a single question. RESULTS: Patients who answered yes to PASS showed a significantly better overall mean DAPSA score than those who were not in PASS. Furthermore, patients in PASS showed a significantly lower level of systemic inflammation, lower Leeds Enthesitis Index score, a significantly lower impact of disease (PsAID), lower pain and better function than patients who answered no to PASS. A moderate to good agreement was found between PASS, MDA, DAPSA low disease activity and PsAID score ≤4. Good sensitivity and specificity were found with PASS with respect to DAPSA low disease activity, and although PASS is sensitive in the identification of patients with MDA, DAPSA remission and VLDA it lacks of specificity. DISCUSSION: This study showed that PASS might be used as an alternative to determine disease activity in patients with PsA in real clinical practice, mainly in patients with low disease activity according to DAPSA criteria.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Lubrano E, Scriffignano S, Azuaga AB, et al. Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices. RMD Open. 2020. PMID: 32179713. doi:10.1136/rmdopen-2020-001170

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。